Competitive 4-[[5-(4-Methylphenyl)-3-Trifluoromethyl]-1H-Pyrazol-Yl]Benzenesulfonamide prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to
sales7@alchemist-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@alchemist-chem.com
As a leading 4-[[5-(4-Methylphenyl)-3-Trifluoromethyl]-1H-Pyrazol-Yl]Benzenesulfonamide supplier, we deliver high-quality products across diverse grades to meet evolving needs, empowering global customers with safe, efficient, and compliant chemical solutions.
What is the chemical structure of 4- [[5- (4-methylphenyl) -3-trifluoromethyl] -1H-pyrazolyl] benzenesulfonamide?
The chemical structure of 4- [[5- (4-methylbenzyl) -3-trifluoromethyl] -1H-pyrazolyl] benzothiazole is a complex and interesting subject in the field of organic chemistry.
In this compound structure, the core part is the benzothiazole ring, which has unique chemical activity and physical properties. The benzothiazole ring is formed by fusing the benzene ring and the thiazole ring, which endows the molecule with certain rigidity and stability. The presence of sulfur and nitrogen atoms in the thiazole ring alters the distribution of the molecular electron cloud, affecting its reactivity and spectral properties. The substituents associated with
have a great influence on the overall structure and properties. Among them, the 4- [[5- (4-methylbenzyl) -3-trifluoromethyl] -1H-pyrazolyl] part, pyrazolyl is a five-membered heterocycle containing two adjacent nitrogen atoms, which has good coordination ability and biological activity. The substitution of (4-methylbenzyl) at the 5-position introduces the benzyl structure to increase the hydrophobicity and spatial resistance of the molecule; the presence of methyl groups further fine-tunes the electron cloud density. Trifluoromethyl in the 3-position, due to the strong electronegativity of the fluorine atom, the molecular polarity increases, which affects its solubility, stability and biological activity.
The interaction of various parts of this chemical structure determines the physical and chemical properties of the compound. It may have potential application value in the fields of medicinal chemistry, materials science, etc. For example, it can be optimized as a lead compound to develop drugs with specific biological activities, or applied to the design and synthesis of new functional materials.
What are the main physical properties of 4- [[5- (4-methylphenyl) -3-trifluoromethyl] -1H-pyrazolyl] benzenesulfonamide?
The main physical properties of 4- [[5- (4-methylphenyl) -3-trifluoromethyl] -1H-indole-2-carboxylic acid are as follows:
This compound is usually in solid form. Its melting point is crucial for identification and purity judgment. Different purity and crystal structure may lead to differences in melting point. Accurate determination of melting point helps to determine its chemical purity and structural characteristics.
In terms of solubility, its solubility in organic solvents is more critical. Generally speaking, it will have a certain solubility in common organic solvents such as dichloromethane, chloroform, N, N-dimethylformamide (DMF), etc. In dichloromethane, due to the non-polarity of dichloromethane and the similarity of the partial structure of the compound, it can be well dissolved, which makes in organic synthesis, dichloromethane can often be used as a reaction solvent or for recrystallization to purify the product. In water, because the compound contains more hydrophobic groups, such as methyl phenyl, trifluoromethyl, etc., its solubility is extremely low and almost insoluble.
The density of this compound is also an important physical property. Although its exact value needs to be accurately determined by experiments, the approximate density range can be estimated based on its molecular structure and the type and quantity of atoms contained. Its molecules contain carbon, hydrogen, nitrogen, oxygen, fluorine and other atoms. Due to the large relative atomic mass and high electronegativity of fluorine atoms, the overall density will be affected.
In addition, its appearance may appear white to light yellow powder or crystalline, which is not only related to purity, but also affected by the synthesis method and crystallization conditions. If there are fewer impurities and suitable crystallization conditions during the synthesis process, regular and lighter crystals may be obtained; conversely, if there are more impurities or poor crystallization conditions, it may appear powdery and darker.
4- [[5- (4-methylphenyl) -3-trifluoromethyl] -1H-pyrazolyl] benzenesulfonamide is used in what fields?
4- [[5- (4-methylbenzyl) -3-trifluoromethyl] -1H-pyrazole] benzylquinazoline has important applications in the fields of medicine and pesticides.
In the field of medicine, such compounds exhibit potential biological activities due to their unique chemical structures. For example, they may be used as lead compounds for anti-cancer drugs. Studies have shown that compounds containing pyrazole and quinazoline structural units have inhibitory effects on the proliferation of certain cancer cells. Substituents such as methyl benzyl and trifluoromethyl in its structure can regulate the interaction between compounds and biological targets, and affect their absorption, distribution, metabolism and excretion processes in the body, thus potentially improving the efficacy and selectivity of drugs and reducing toxic and side effects.
In the field of pesticides, this class of compounds is expected to be developed as efficient fungicides or insecticides. The structures of pyrazole and quinazoline endow them with certain bactericidal and insecticidal activities. By modifying its structure, such as changing the type, location and quantity of substituents, its control effect on different crop diseases and insect pests can be optimized. The introduction of trifluoromethyl can enhance the lipid solubility of compounds, making it easier to penetrate the cell membranes of pests or pathogens, and enhance the efficacy of drugs. In addition, the compound may also have good environmental compatibility, with little impact on the ecological environment, in line with the trend of modern pesticide development.
What is the preparation method of 4- [[5- (4-methylphenyl) -3-trifluoromethyl] -1H-pyrazolyl] benzenesulfonamide?
To prepare 4- [[5 - (4 - methylbenzyl) - 3 - trifluoromethyl] - 1H - indolyl] indolquinoline, the method is as follows:
First take an appropriate amount of 5- (4 - methylbenzyl) - 3 - trifluoromethyl - 1H - indole and place it in a clean reaction vessel. Prepare a suitable solvent to fully dissolve the indole derivative to create a homogeneous reaction environment.
Take another indolquinoline precursor containing the corresponding substituent and slowly add it to the above reaction system according to the stoichiometric ratio. In this process, the reaction temperature needs to be finely regulated to maintain within a specific range. This temperature is indeed related to the reaction rate and product selectivity, and must not be ignored.
Then, an appropriate amount of catalyst is added, which can effectively reduce the activation energy of the reaction and accelerate the reaction process. The amount of catalyst also needs to be precisely controlled, so that too much or side reactions can breed, and too little will slow down the reaction.
During the reaction, a stirring device is used to fully mix the system to ensure that the reactant molecules are fully contacted and collided to promote the reaction. At the same time, by monitoring means, such as thin-layer chromatography (TLC) or high-performance liquid chromatography (HPLC), the reaction process can be observed in real time, and the reaction can be stopped in time when the raw materials are exhausted and the amount of product generated reaches the expected amount.
After the reaction is completed, pour the reaction mixture into an appropriate amount of separation vessel, apply the extraction method, and select a suitable extractant to transfer the target product to the organic phase. Then, the organic phase is washed and dried to remove impurities and moisture.
Finally, the crude product is refined by column chromatography or recrystallization to obtain pure 4- [[5- (4-methylbenzyl) -3-trifluoromethyl] -1H-indolyl] indolequinoline. The whole preparation process requires strict compliance with the operating procedures and attention to detail to obtain the ideal product yield and purity.
What are the market prospects for 4- [[5- (4-methylphenyl) -3-trifluoromethyl] -1H-pyrazolyl] benzenesulfonamide?
4- [[5- (4-methylphenyl) -3-trifluoromethyl] -1H-pyrazole] thiazolopyridine drugs are actually related to many factors in terms of market prospects.
Guanfu such drugs have unique chemical structures and are composed of specific groups. Among them, methylphenyl, trifluoromethyl, pyrazole, thiazolopyridine and other structural units endow it with unique physical and chemical properties and biological activities. In terms of pharmacological properties, this structure may give it a unique target and mechanism of action, which holds potential application value in the field of disease treatment.
As far as the current pharmaceutical market situation is concerned, with the increasing emphasis on health among the public, the demand for diagnosis and treatment of various diseases is also increasing. The market has always been eagerly anticipating drugs with novel mechanisms of action. If this 4- [[5- (4-methylphenyl) -3-trifluoromethyl] -1H-pyrazole] thiazolopyridine drugs can demonstrate excellent efficacy, such as good therapeutic effect on specific diseases, and good safety and tolerance, they will surely win a place in the market.
However, the market outlook also faces many challenges. The road to new drug research and development is full of thorns. From laboratory research to clinical application, it needs to go through many rigorous trials and approval processes. During the drug development process, it may encounter problems such as poor efficacy and safety issues, which will hinder the research and development process. Even if it is successfully launched, it needs to face fierce market competition. Similar drugs, alternative therapies, etc. will pose a threat to its market share.
But overall, if it can effectively overcome the many difficulties in the process of research and development and marketing activities and fully demonstrate its unique advantages, this 4- [[5- (4-methylphenyl) -3-trifluoromethyl] -1H-pyrazole] thiazolopyridine drugs may gain considerable development prospects in the pharmaceutical market.